TrialAdvances in therapy2025

Efficacy and Safety of 48-Week Low-Dose Dienogest Treatment in Patients with Endometriosis-Associated Dysmenorrhea: A Randomized, Open-Label, Parallel-Group Trial.

Kyoko Kikuno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.